Dynavax Technologies Corp. (DVAX)
15.41
0.00 (0.00%)
USD |
NASDAQ |
Jan 09, 16:00
15.30
-0.11
(-0.71%)
After-Hours: 05:10
Dynavax Technologies Research and Development Expense (Quarterly): 19.12M for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Merck & Co., Inc. | 3.552B |
| Amicus Therapeutics, Inc. | 23.42M |
| Agios Pharmaceuticals, Inc. | 85.42M |
| Hyperion DeFi, Inc. | 0.3739M |
| Edgewise Therapeutics, Inc. | 36.96M |